Cited by 2,712Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeAutoimmune and Inflammatory Disorders

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Inflammatory Bowel Disease

Open access

Abraham, Clara, Cho, Judy H.·2009·New England Journal of Medicine

Open this paper in CoChat — free account Open PDF

Abstract

more than 50 distinct clinical collections, which can be used as convenient entry points to clinical content.In each collection, articles are cited in reverse chronologic order, with the most recent first.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra0804647

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S. K., Wise, R. P., Mirabile‐Levens, E., Kasznica, J. M., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,683
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., Granucci, F., Kraehenbuhl, J.-P., & Ricciardi‐Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/86373 · Cited by 2,554

Flagged first, then by citations

Show all 104 references

Research works printed but not linked: 6

Musch MW, 2002, J Clin Invest, 110, 1739, 10.1172/JCI0215695 · DOI
Vijay-Kumar M, 2007, J Clin Invest, 117, 3909
10.1172/JCI19229 · DOI
Kamada N, 2008, J Clin Invest, 118, 2269
Watanabe T, 2008, J Clin Invest, 118, 545
Sugimoto K, 2008, J Clin Invest, 118, 534

Sorted by citations

Items 101–200 of 1,008

Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation
Xiao, B., Zhang, Z., Viennois, É., Kang, Y., Zhang, M., Han, M. K., Chen, J., & Merlin, D. (2016) · Theranostics · doi:10.7150/thno.15710 · Cited by 242
Air pollution: An environmental factor contributing to intestinal disease
Beamish, L. A., Osornio-Vargas, Á. R., & Wine, E. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.02.017 · Cited by 237
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis
Kump, P. K., Gröchenig, H.-P., Lackner, S., Trajanoski, S., Reicht, G., Hoffmann, K. M., Deutschmann, A., Wenzl, H. H., Petritsch, W., Krejs, G. J., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829ea325 · Cited by 235
Resveratrol and inflammatory bowel disease: the evidence so far
Nunes, S. P., Danesi, F., Rio, D. D., & Silva, P. (2017) · Nutrition Research Reviews · doi:10.1017/s095442241700021x · Cited by 236
Crohn's disease: NOD2, autophagy and ER stress converge
Fritz, T. M. J., Niederreiter, L., Adolph, T. E., Blumberg, R. S., & Kaser, A. (2011) · Gut · doi:10.1136/gut.2009.206466 · Cited by 249
Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohnʼs Disease
Vaughn, B. P., Vatanen, T., Allegretti, J. R., Bai, A., Xavier, R. J., Korzenik, J. R., Gevers, D., Ting, A., Robson, S. C., & Moss, A. C. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000893 · Cited by 238
TGR 5 signalling inhibits the production of pro‐inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
Yoneno∥, K., Hisamatsu, T., Shimamura, K., Kamada, N., Ichikawa, R., Kitazume, M. T., Mori, M., Uo, M., Namikawa, Y., Matsuoka, K., et al. (2013) · Immunology · doi:10.1111/imm.12045 · Cited by 236
Review article: vitamin D and inflammatory bowel diseases
Mouli, V. P., & Ananthakrishnan, A. N. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12553 · Cited by 234
Significance of the microbiome in obstructive lung disease
Han, M. K., Huang, Y. J., LiPuma, J. J., Boushey, H. A., Boucher, R. C., Cookson, W., Curtis, J. L., Erb‐Downward, J. R., Lynch, S. V., Sethi, S., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201183 · Cited by 235
CD 4+ T‐cell subsets in intestinal inflammation
Shale, M., Schiering, C., & Powrie, F. M. (2013) · Immunological Reviews · doi:10.1111/imr.12039 · Cited by 230
Clinical importance of IL-22 cascade in IBD
Mizoguchi, A., Yano, A., Himuro, H., Ezaki, Y., Sadanaga, T., & Mizoguchi, E. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1401-7 · Cited by 226
Oral contraceptives, reproductive factors and risk of inflammatory bowel disease
Khalili, H., Higuchi, L. M., Ananthakrishnan, A. N., Richter, J. M., Feskanich, D., Fuchs, C. S., & Chan, A. T. (2012) · Gut · doi:10.1136/gutjnl-2012-302362 · Cited by 218
Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease
Limdi, J. K., Aggarwal, D., & McLaughlin, J. T. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000585 · Cited by 216
Biomarkers in inflammatory bowel disease: current practices and recent advances.
Iskandar, H. N., & Ciorba, M. A. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.001 · Cited by 210
Fecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner‐Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774.pub2 · Cited by 217
“One of the proposed mechanisms for the development of IBD involves the interplay between microbes and the immune system, which may then lead to an abnormal inflammatory response in genetically susceptible individuals (Abraham 2009; Cleynen 2016).”
BackgroundInfluential
Mycobiota in gastrointestinal diseases
Mukherjee, P. K., Sendid, B., Hoarau, G., Colombel, J., Poulain, D., & Ghannoum, M. A. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.188 · Cited by 215
Securing the immune tightrope: mononuclear phagocytes in the intestinal lamina propria
Varol, C., Zigmond, E., & Jung, S. (2010) · Nature reviews. Immunology · doi:10.1038/nri2778 · Cited by 222
A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota
Li, C., Yang, Z., Cheng, J., Guo, J., Zhang, Q., Zhang, X., Ren, J., Wang, F., Huang, J., Hu, H., et al. (2019) · Advanced Science · doi:10.1002/advs.201900610 · Cited by 209
Temporal Dynamics of Host Molecular Responses Differentiate Symptomatic and Asymptomatic Influenza A Infection
Huang, Y., Zaas, A. K., Rao, A., Nicolas Dobigeon, B., WOOLF, P. J., Veldman, T., Øien, N. C., McClain, M. T., Varkey, J. B., Nicholson, B. P., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002234 · Cited by 208
Intestinal Microbes in Inflammatory Bowel Diseases
Sartor, R. B., & Mazmanian, S. K. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.4 · Cited by 206
Association Between Parkinsonʼs Disease and Inflammatory Bowel Disease
Lin, J.-C., Lin, C., Hsu, C.-W., Lin, C., & Kao, C. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000735 · Cited by 203
Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function
Tambuwala, M. M., Cummins, E. P., Lenihan, C. R., Kiss, J., Stauch, M., Scholz, C. C., Fraisl, P., Lasitschka, F., Mollenhauer, M., Saunders, S. P., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.068 · Cited by 204
Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
Lu, Q., Yang, M.-F., Liang, Y.-J., Xu, J., Xu, H.-M., Nie, Y.-Q., Wang, L.-S., Yao, J., & Li, D.-F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s353038 · Cited by 222
Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn’s Disease
Craven, M. D., Egan, C. E., Dowd, S. E., McDonough, S. P., Dogan, B., Denkers, E., Bowman, D. D., Scherl, E., & Simpson, K. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041594 · Cited by 197
Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment
Kasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199
The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation
Kabat, A. M., Harrison, O. J., Riffelmacher, T., Moghaddam, A. E., Pearson, C. F., Laing, A., Abeler-Dörner, L., Forman, S. P., Grencis, R. K., Sattentau, Q., et al. (2016) · eLife · doi:10.7554/elife.12444 · Cited by 193
Intestinal Epithelium in Inflammatory Bowel Disease
Coskun, M. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00024 · Cited by 212
An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice
Vong, L. B., Tomita, T., Yoshitomi, T., Matsui, H., & Nagasaki, Y. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.043 · Cited by 196
Environmental Risk Factors for Inflammatory Bowel Diseases: A Review
Ananthakrishnan, A. N. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3350-9 · Cited by 196
Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women
Li, W., Han, J., Chan, A. T., & Qureshi, A. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202143 · Cited by 195
Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
Gadaleta, R. M., Oldenburg, B., Willemsen, E. C. L., Spit, M., Murzilli, S., Salvatore, L., Klomp, L. W. J., Siersema, P. D., van Erpecum, K. J., & van Mil, S. W. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.005 · Cited by 195
SAMP1/YitFc mouse strain: A spontaneous model of Crohnʼs disease-like ileitis
Pizarro, T. T., Pastorelli, L., Bamias, G., Garg, R. R., Reuter, B. K., Mercado, J. R., Chieppa, M., Arseneau, K. O., Ley, K., & Cominelli, F. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21638 · Cited by 192
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
Basu, S., & Dittel, B. N. (2011) · Immunologic Research · doi:10.1007/s12026-011-8210-5 · Cited by 197
Death in the intestinal epithelium—basic biology and implications for inflammatory bowel disease
Blander, J. M. (2016) · FEBS Journal · doi:10.1111/febs.13771 · Cited by 197
Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1
Wu, H., Fan, H., Shou, Z., Xu, M., Chen, Q., Ai, C., Dong, Y., Liu, Y., Nan, Z., Wang, Y., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.12.043 · Cited by 197
A high-sugar diet rapidly enhances susceptibility to colitis via depletion of luminal short-chain fatty acids in mice
Laffin, M., Fedorak, R., Zalasky, A., Park, H., Gill, A., Agrawal, A., Keshteli, A. H., Hotte, N., & Madsen, K. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-48749-2 · Cited by 196
Genetic Variants Synthesize to Produce Paneth Cell Phenotypes That Define Subtypes of Crohn's Disease
VanDussen, K. L., Liu, T., Li, D., Towfic, F., Modiano, N., Winter, R. W., Haritunians, T., Taylor, K. D., Dhall, D., Targan, S. R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.048 · Cited by 202
Ginseng root extract attenuates inflammation by inhibiting the MAPK/NF-κB signaling pathway and activating autophagy and p62-Nrf2-Keap1 signaling in vitro and in vivo
Song, Y., Li, F., Lu, S., Ren, L., Bian, S., Liu, M., Zhao, D., Wang, S., & Wang, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114739 · Cited by 198
Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation
Lian, Q., Xu, J., Yan, S., Huang, M., Ding, H., Sun, X., Bi, A., Ding, J., Sun, B., & Geng, M. (2017) · Cell Research · doi:10.1038/cr.2017.54 · Cited by 191
Roles of Macrophages in the Development and Treatment of Gut Inflammation
Han, X., Ding, S., Jiang, H., & Liu, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.625423 · Cited by 196
“When IBD occurs, it is often accompanied by the death of intestinal epithelial cells (Abraham and Cho, 2009).”
Background
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Raman, R., Patel, K. J., & Ranjan, K. (2021) · Biomolecules · doi:10.3390/biom11070993 · Cited by 194
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation
Thibaut, M. M., & Bindels, L. B. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.12.006 · Cited by 193
NAD metabolism fuels human and mouse intestinal inflammation
Gerner, R. R., Klepsch, V., Macheiner, S., Arnhard, K., Adolph, T. E., Grander, C., Wieser, V., Pfister, A., Moser, P., Hermann-Kleiter, N., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314241 · Cited by 192
Gut-innervating nociceptors regulate the intestinal microbiota to promote tissue protection
Zhang, W., Lyu, M., Bessman, N. J., Xie, Z., Arifuzzaman, M., Yano, H., Parkhurst, C. N., Chu, C., Zhou, L., Putzel, G., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.008 · Cited by 185
Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease
Wasilewski, A., Zielińska, M., Storr, M., & Fichna, J. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000364 · Cited by 195
“It regularly occurs in the intestinal biopsies of patients with IBD and the milk of nursing mothers diagnosed with CD; the antibodies against Mycobacterium avium paratuberculosis spp. have been detected in more than 83% subjects with CD.17 Moreover, Mycobacterium is involved in the initiation of John’s disease occurri…”
BackgroundInfluential
Inflammatory Bowel Disease
Malik, T. A. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.07.006 · Cited by 181
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
Decara, J. M., Rivera, P., López-Gambero, A. J., Serrano, A., Pavón, F. J., Baixerás, E., de Fonseca, F. R., & Suárez, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00730 · Cited by 186
“While the inflammation in UC is normally restricted to the mucosal layer of the entire colon in an uninterrupted pattern, the inflammation in CD is typically confined to the mucosa layer of the colon (Abraham and Cho, 2009).”
Background
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
Scott, F. I., Mamtani, R., Brensinger, C. M., Haynes, K., Fuxench, Z. C. C., Zhang, J., Chen, L., Xie, F., Yun, H., Osterman, M. T., et al. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2015.3029 · Cited by 183
Paneth cells and innate mucosal immunity
Ouellette, A. J. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32833dccde · Cited by 195
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
Danese, S., Grisham, M. B., Hodge, J. A., & Telliez, J. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00311.2015 · Cited by 181
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease
Limketkai, B. N., Iheozor‐Ejiofor, Z., Gjuladin-Hellon, T., Parian, A. M., Matarese, L. E., Bracewell, K., MacDonald, J. K., Gordon, M. A., & Mullin, G. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012839.pub2 · Cited by 182
“Factors that contribute to the development of IBD are unclear, although the current paradigm of pathogenesis involves the interaction of disease-susceptibility genes, inappropriate immune response, gut microbiota, and environmental factors (Abraham 2009).”
Background
Characterization of Microbial Dysbiosis and Metabolomic Changes in Dogs with Acute Diarrhea
Guard, B. C., Barr, J. W., Reddivari, L., Klemashevich, C. L., Jayaraman, A., Steiner, J. M., Vanamala, J., & Suchodolski, J. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127259 · Cited by 202
Neutrophil Extracellular Traps in Ulcerative Colitis
Bennike, T. B., Carlsen, T. G., Ellingsen, T., Bonderup, O. K., Glerup, H., Bøgsted, M., Christiansen, G., Birkelund, S., Stensballe, A., & Andersen, V. C. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000460 · Cited by 190
Genetics and Environmental Interactions Shape the Intestinal Microbiome to Promote Inflammatory Bowel Disease Versus Mucosal Homeostasis
Sartor, R. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.10.036 · Cited by 164
Dietary Inflammatory Potential and Risk of Crohn’s Disease and Ulcerative Colitis
Lo, C., Lochhead, P. J., Khalili, H., Song, M., Tabung, F. K., Burke, K. E., Richter, J. M., Giovannucci, E. L., Chan, A. T., & Ananthakrishnan, A. N. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.011 · Cited by 197
A Modular Organization of the Human Intestinal Mucosal Microbiota and Its Association with Inflammatory Bowel Disease
Tong, M., Li, X., Parfrey, L. W., Roth, B. E., Ippoliti, A., Wei, B., Borneman, J., McGovern, D. P. B., Frank, D. N., Li, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080702 · Cited by 184
Ambient air pollution correlates with hospitalizations for inflammatory bowel disease
Ananthakrishnan, A. N., McGinley, E. L., Binion, D. G., & Saeian, K. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21455 · Cited by 183
NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2
Muise, A. M., Xu, W., Guo, C., Walters, T. D., Wolters, V. M., Fattouh, R., Lam, G. Y., Hu, P., Murchie, R., Sherlock, M. E., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300078 · Cited by 178
“INTRODUCTION Inflammatory bowel diseases (IBD) are hypothesised to occur in genetically susceptible individuals as a result of dysregulated immune responses to gut flora after exposure to an as yet unidentified environmental stimulus.(1) 2 Investigation of diseases that present with intestinal inflammation that are si…”
Background
Oxidative stress in ulcerative colitis: an old concept but a new concern
Jena, G., Trivedi, P. P., & Sandala, B. (2012) · Free Radical Research · doi:10.3109/10715762.2012.717692 · Cited by 177
Oral delivery of micro/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives
dos Santos, A. M., Carvalho, S. G., Meneguin, A. B., Sábio, R. M., Gremião, M. P. D., & Chorilli, M. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.026 · Cited by 178
The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy
Guzel, T., & Mirowska-Guzel, D. M. (2022) · Molecules · doi:10.3390/molecules27051680 · Cited by 176
The role of hypoxia in inflammatory disease (Review)
Biddlestone, J., Bandarra, D., & Rocha, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2079 · Cited by 183
Systematic review with meta‐analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease
Swaminath, A. C., Feathers, A., Ananthakrishnan, A. N., Falzon, L., & Ferry, S. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14253 · Cited by 175
Inflammatory Bowel Disease and Parkinson’s Disease: A Nationwide Swedish Cohort Study
Weimers, P., Halfvarson, J., Sachs, M. C., Saunders-Pullman, R. J., Ludvigsson, J. F., Peter, I., Burisch, J. M., & Olén, O. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy190 · Cited by 173
Investigating the biological and clinical significance of human dysbioses
Frank, D. N., Zhu, W., Sartor, R. B., & Li, E. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.06.005 · Cited by 182
Transcriptomic landscape of lncRNAs in inflammatory bowel disease
Mirza, A. H., Bang‐Berthelsen, C. H., Seemann, S. E., Pan, X., Frederiksen, K. S., VILIEN, M., Gorodkin, J., & Pociot, F. (2015) · Genome Medicine · doi:10.1186/s13073-015-0162-2 · Cited by 176
Murine colitis reveals a disease-associated bacteriophage community
Duerkop, B. A., Kleiner, M., Páez-Espino, D., Zhu, W., Bushnell, B., Hassell, B., Winter, S., Kyrpides, N. C., & Hooper, L. V. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0210-y · Cited by 173
Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
Dorofeyev, A. E., Василенко, И. В., Rassokhina, O. A., & Kondratyuk, R. B. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/431231 · Cited by 183
Strategies targeting the IL-4/IL-13 axes in disease
May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166
Comparing histological activity indexes in UC
Bressenot, A., Salleron, J., Bastien, C., Danese, S., Boulagnon‐Rombi, C., & Peyrin‐Biroulet, L. (2014) · Gut · doi:10.1136/gutjnl-2014-307477 · Cited by 170
The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract
Bilski, J., Mazur-Biały, A. I., Wójcik-Grzybek, D., Zahradnik-Bilska, J., Brzozowski, B., Magierowski, M., Mach, T., Magierowska, K., & Brzozowski, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/9074601 · Cited by 174
Disappointing Durable Remission Rates in Complex Crohnʼs Disease Fistula
Molendijk, I., Nuij, V. J. A. A., Jong, A. E. V. D. M., & van der Woude, C. J. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000148 · Cited by 169
Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease
Ananthakrishnan, A. N., Shi, H. Y., Tang, W., Law, C. C. Y., Sung, J. J. �., Chan, F. K. L., & Ng, S. C. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw054 · Cited by 175
Palmatine ameliorated murine colitis by suppressing tryptophan metabolism and regulating gut microbiota
Zhang, X., Yuan, Z., Qu, C. F., Yu, X., Huang, T., Chen, V. P., Su, Z., Dou, Y., Wu, J., Zeng, H., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.010 · Cited by 167
Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum
Biswas, A., Liu, Y.-J., Hao, L., Mizoguchi, A., Salzman, N. H., Bevins, C. L., & Kobayashi, K. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003363107 · Cited by 166
The price of immunity
Goldszmid, R. S., & Trinchieri, G. (2012) · Nature Immunology · doi:10.1038/ni.2422 · Cited by 175
Next generation of small molecules in inflammatory bowel disease
Olivera, P., Danese, S., & Peyrin-Biroulet, L. (2017) · Gut · doi:10.1136/gutjnl-2016-312912 · Cited by 154
Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease
Chen, W., & Chi, C. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2019.0891 · Cited by 171
Genetic disorders coupled to ROS deficiency
O’Neill, S., Brault, J., Stasia, M.-J., & Knaus, U. G. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.009 · Cited by 164
The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology
Kiss, M., Czimmerer, Z., & Nagy, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.044 · Cited by 166
Intraluminal Containment of Commensal Outgrowth in the Gut during Infection-Induced Dysbiosis
Molloy, M. J., Grainger, J. R., Bouladoux, N. J., Hand, T. W., Koo, L. Y., Naik, S., Quiñones, M., Dzutsev, A., Gao, J., Trinchieri, G., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.003 · Cited by 156
A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6
Yang, S., Liang, X., Song, J. M., Li, C., Liu, A., Luo, Y., Ma, H., Tan, Y. J., & Zhang, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02404-8 · Cited by 162
Keep calm: the intestinal barrier at the interface of peace and war
Thoo, L., Noti, M., & Krebs, P. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2086-z · Cited by 168
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Campanati, A., Marani, A., Martina, E., Diotallevi, F., Radi, G., & Offidani, A. (2021) · Biomedicines · doi:10.3390/biomedicines9111511 · Cited by 159
Risks of Serious Infection or Lymphoma With Anti–Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review
Dulai, P. S., Thompson, K. D., Blunt, H. B., Dubinsky, M. C., & Siegel, C. A. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.01.021 · Cited by 158
Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential
Sela-Passwell, N., Kikkeri, R. V., Dym, O., Rozenberg, H., Margalit, R., Arad‐Yellin, R., Eisenstein, M., Brenner, O. J., Shoham, T., Danon, T., et al. (2011) · Nature Medicine · doi:10.1038/nm.2582 · Cited by 158
Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts
Khalili, H., Ananthakrishnan, A. N., Konijeti, G. G., Liao, X., Higuchi, L. M., Fuchs, C. S., Spiegelman, D. L., Richter, J. M., Korzenik, J. R., & Chan, A. T. (2013) · BMJ · doi:10.1136/bmj.f6633 · Cited by 171
Fecal transplantation for treatment of inflammatory bowel disease
Imdad, A., Nicholson, M. R., Tanner‐Smith, E. E., Zackular, J. P., Gomez-Duarte, O. G., Beaulieu, D. B., & Acra, S. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012774 · Cited by 160
Linking Obesity with Colorectal Cancer: Epidemiology and Mechanistic Insights
Ye, P., Xi, Y., Huang, Z., & Xu, P. (2020) · Cancers · doi:10.3390/cancers12061408 · Cited by 168
Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study
Ananthakrishnan, A. N., Khalili, H., Pan, A., Higuchi, L. M., de Silva, P., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.032 · Cited by 155
TGR5 and Immunometabolism: Insights from Physiology and Pharmacology
Perino, A., & Schoonjans, K. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.002 · Cited by 157
Serum Analysis of Tryptophan Catabolism Pathway: Correlation With Crohnʼs Disease Activity
Gupta, N., Thaker, A. I., Kanuri, N. D., Riehl, T. E., Rowley, C. W., Stenson, W. F., & Ciorba, M. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21849 · Cited by 159
XIAP variants in male Crohn's disease
Zeißig, Y., Petersen, B., Milutinovic, S., Bosse, E., Mayr, G., Peuker, K., Hartwig, J., Keller, A., Kohl, M., Laass, M. W., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306520 · Cited by 156
Blastocystis: getting to grips with our guileful guest
Scanlan, P. D., & Stensvold, C. R. (2013) · Trends in Parasitology · doi:10.1016/j.pt.2013.08.006 · Cited by 165
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease
Caso, F., Galozzi, P., Costa, L., Sfriso, P., Cantarini, L., & Punzi, L. (2015) · RMD Open · doi:10.1136/rmdopen-2015-000097 · Cited by 156
IL-10 in Humans: Lessons from the Gut, IL-10/IL-10 Receptor Deficiencies, and IL-10 Polymorphisms
Engelhardt, K. R., & Grimbacher, B. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-43492-5_1 · Cited by 156
Innate Lymphoid Cells in Intestinal Inflammation
Geremia, A., & Arancibia-Cárcamo, C. V. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01296 · Cited by 170
Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development
Park, J., Choi, J. W., Jhun, J., Kwon, J. Y., Lee, B., Yang, C. W., Park, S., & Cho, M. (2018) · Journal of Medicinal Food · doi:10.1089/jmf.2017.3990 · Cited by 154
The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation
Lü, D., Liu, L., Ji, X., Gao, Y., Chen, X., Liu, Y., Liu, Y., Zhao, X., Li, Y., Li, Y., et al. (2015) · Nature Immunology · doi:10.1038/ni.3278 · Cited by 154
Functional Impacts of the Intestinal Microbiome in the Pathogenesis of Inflammatory Bowel Disease
Li, J. S. Y., Butcher, J., Mack, D. R., & Stintzi, A. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000215 · Cited by 152

Authors: Abraham, C., & Cho, J. H.
Affiliations: Yale University (US)
ORCID: Abraham, Clara
Cho, Judy H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2009-11-19
Volume: 361
Issue: 21
Pages: 2066-2078
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra0804647
PMC: PMC3491806
OpenAlex: W4244626580
Cited by: 2,712
References: 104
Citations by year: 2026: 94 · 2025: 137 · 2024: 169 · 2023: 151 · 2022: 171 · 2021: 184 · 2020: 237 · 2019: 189 · 2018: 193 · 2017: 182 · 2016: 171 · 2015: 217 · 2014: 174 · 2013: 142 · 2012: 120
FWCI: 9.21
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Crohn's and Colitis Foundation of America (DK062422, R01DK077905)
Crohn's and Colitis Foundation
National Institutes of Health (DK P30-34989, U01 DK62429)
Takeda Oncology
National Institute of Diabetes and Digestive and Kidney Diseases (DK P30 34989, U01-DK62429, R01DK072373, R01DK077905, RC1DK086800, U01DK062429, P30DK034989, U01DK062422)
National Center for Research Resources (UL1RR024139)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Health Sciences › Medicine › Dermatology › Autoimmune and Inflammatory Disorders
Keywords: inflammatory bowel disease
MeSH terms: Animals, Colitis, Ulcerative, Crohn Disease, Humans, Immunity, Innate, Intestinal Mucosa, T-Lymphocytes, Inflammatory Bowel Diseases, Interleukin-23, Metagenome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammatory Bowel Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks